The goal of this clinical trial is to describe the cardiac and systemic inflammatory adaptations specific to women practicing ultra-endurance sports. The objectives are to: * Improve the understanding of cardiac and systemic inflammatory adaptations specific to women participating in ultra-endurance sports. * Assess the relationship between observed cardiac and systemic inflammatory alterations and the relative levels of estrogen, testosterone, and progesterone. * Describe the vascular adaptations specific to women participating in ultra-endurance sports. * Examine the influence of defense mechanisms on the emotional dynamics observed during and after an ultra-endurance race.
No linked publications found in PubMed
Inclusion Criteria: * Must have a Global Positioning System watch during the race; * Must participate in one of the following races: * "Ecotrail de Paris Ile France©" (=a trail running race in the Paris region, it is not possible to translate; it is a registered trademark) 80 kilometers; * Or "la 6000D©" 69 kilometers; * Must comply with the race regulations: * Medical certificate stating no contraindications to competitive running, dated less than 12 months prior to the race; * Or a valid sports license on the day of the race. * Must agree to participate in the study, sign the consent form, and allow the sponsor to use their data for the purposes of this study. Exclusion Criteria: * Refusal or linguistic or mental incapacity to sign the informed consent form; * Person under guardianship (conservatorship, curators, or legal protection) or deprived of liberty; * Person not affiliated with a social security scheme; * Pregnant woman; * Person participating in a drug study; * Women with a medical history (chronic lung disease, heart disease, pharmacologically treated hypertension) or with a known significant chronic inflammatory disease at the time of the enrollment visit; * Person who has already participated in this study in a previous race.